Women who use estrogen-only hormone replacement therapy don't appear to be at increased risk of dying from lung cancer.
That's according to a new analysis of earlier data from postmenopausal women who had had their uterus removed (hysterectomy).
Previous studies of women with intact uteruses had shown that taking combined estrogen and progestin -- a synthetic version of the hormone progesterone -- raised the chances of dying from lung cancer (see Reuters Health story of September 21, 2009).(Read entire article)
While previous studies found increased lung cancer mortality in women taking estrogen-progestin combo therapy, the outcomes of estrogen-alone therapy on postmenopausal women with previous hysterectomy were not clear.
Estrogen-progestin therapy was also linked to an increased risk of heart attack, stroke, breast cancer, and blood clots in postmenopausal women. (Read entire article)